loading page

Comparison of expectant vs. excisional/ablative management for CIN2 in the era of HPV testing.
  • +2
  • Kevin Tjandraprawira,
  • Adeola Olaitan,
  • Aviva Petrie,
  • Nafisa Wilkinson,
  • Adam Rosenthal
Kevin Tjandraprawira
University College London EGA Institute for Women's Health
Author Profile
Adeola Olaitan
University College London Hospitals NHS Foundation Trust
Author Profile
Aviva Petrie
University College London Eastman Dental Institute
Author Profile
Nafisa Wilkinson
University College London Hospitals NHS Foundation Trust
Author Profile
Adam Rosenthal
University College London EGA Institute for Women's Health
Author Profile

Abstract

Objective: To investigate conservative and excisional/ablative treatment outcomes for cervical intraepithelial neoplasia grade 2 (CIN2) following introduction of virological test of cure. Design: Retrospective study of prospectively collected data. Setting: Teaching hospital colposcopy unit. Population: 331 sequential biopsy-proven CIN2 cases. Methods: CIN2 cases diagnosed 01/07/2014-31/12/2017 were followed-up until colposcopy discharge and then using the national cervical cytology database. Outcomes were defined: Cytological/histological regression was absence of high-grade CIN on biopsy and/or high-grade dysplasia; Virological regression was cytological/histological regression and negative human papillomavirus testing; Persistence was biopsy-proven CIN2 and/or moderate dyskaryosis; Progression was biopsy-proven CIN3+ and/or severe dyskaryosis. Main outcome measures: Regression, persistence, progression rates; median regression/progression times; referral to discharge interval; subsequent CIN. Results: Median follow-up was 22.6 months (range: 1.9-65.1). 175 (52.9%) patients were initially managed conservatively. 77.3%(133/172) regressed, 13.4%(23/172) persisted and 9.3%(16/172) progressed to CIN3+. 97(56.4%) patients achieved virological regression. Median regression and progression times were 6.1 (range 2.4-30.4) months and 7.6 (range 3.8-43.3) months, respectively. 156 (47.1%) patients underwent initial excision/ablation, with a 89.4%(110/123) virological cure rate. Patients managed conservatively vs. planned excision spent a median of 16.4 and 11.7 months respectively, within colposcopy follow-up. 7 (4.0%) and 3 (1.9%) patients developed further CIN in the conservative and treatment groups respectively, during median 17.2 months post-discharge. Conclusions: Conservative management is a reasonable and effective management strategy in appropriately-selected women with CIN2. The above data provide useful information for clinicians and patients deciding management options. Funding: none Keywords: CIN2; conservative; management; expectant; regression; progression; persistence; excision; HPV; virological